stockrowAlkermes plc (ALKS) vs AMNEAL PHARMACEUTICALS, INC. (AMRX)
- Alkermes plc ALKS 45.66 +2.51%
- AMNEAL PHARMACEUTICALS, INC. AMRX 20.11 +3.39%
Alkermes plc and AMNEAL PHARMACEUTICALS, INC. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc is the larger, with a market value of $7.5B against $6.8B — 1.1× the size. Alkermes plc has negative trailing earnings, so its P/E is not meaningful; AMNEAL PHARMACEUTICALS, INC. trades at 36.9×. Alkermes plc grew revenue faster over the last twelve months: 15.3% against 8.88%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (4.17% vs −0.02%) and the higher return on invested capital (8.45% vs 1.54%). Across the 20 metrics below, Alkermes plc leads on 10 and AMNEAL PHARMACEUTICALS, INC. on 10.
Valuation
Profitability
| Metric | ALKS | AMRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 82.89% | 40.24% | 53.51% |
| Operating margin | 3.66% | 14.99% | 0.00% |
| Net margin | (0.02%) | 4.17% | (2.45%) |
| Free cash flow margin | 13.03% | (1.89%) | 0.00% |
| Return on equity | (0.02%) | (53,107.17%) | (0.80%) |
| Return on assets | (0.01%) | 3.01% | (1.67%) |
| Return on invested capital | 1.54% | 8.45% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack